Clinical Trial Update: Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study

View source ↗

Summary

An observational study evaluating Telmisartan 80 mg combined with hydrochlorothiazide 25 mg for hypertension; results were posted in 2011. Sponsor: Boehringer I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED | Results posted: 2011-04-14